CeriBell (CBLL) Competitors $18.92 +0.30 (+1.58%) As of 07/3/2025 02:41 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. LIVN, WRBY, NVCR, LMAT, EYE, ENOV, CNMD, AORT, CDRE, and TNDMShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include LivaNova (LIVN), Warby Parker (WRBY), NovoCure (NVCR), LeMaitre Vascular (LMAT), National Vision (EYE), Enovis (ENOV), CONMED (CNMD), Artivion (AORT), Cadre (CDRE), and Tandem Diabetes Care (TNDM). These companies are all part of the "medical equipment" industry. CeriBell vs. Its Competitors LivaNova Warby Parker NovoCure LeMaitre Vascular National Vision Enovis CONMED Artivion Cadre Tandem Diabetes Care CeriBell (NASDAQ:CBLL) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, institutional ownership, analyst recommendations, media sentiment and risk. Does the media favor CBLL or LIVN? In the previous week, LivaNova had 2 more articles in the media than CeriBell. MarketBeat recorded 2 mentions for LivaNova and 0 mentions for CeriBell. CeriBell's average media sentiment score of 0.00 equaled LivaNova'saverage media sentiment score. Company Overall Sentiment CeriBell Neutral LivaNova Neutral Do analysts recommend CBLL or LIVN? CeriBell currently has a consensus target price of $32.14, indicating a potential upside of 69.84%. LivaNova has a consensus target price of $59.29, indicating a potential upside of 28.52%. Given CeriBell's higher probable upside, equities research analysts clearly believe CeriBell is more favorable than LivaNova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00LivaNova 0 Sell rating(s) 1 Hold rating(s) 6 Buy rating(s) 1 Strong Buy rating(s) 3.00 Do institutionals and insiders have more ownership in CBLL or LIVN? 97.6% of LivaNova shares are owned by institutional investors. 20.1% of CeriBell shares are owned by insiders. Comparatively, 0.3% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has better valuation and earnings, CBLL or LIVN? LivaNova has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeriBell$65.44M10.45-$40.46MN/AN/ALivaNova$1.25B2.01$63.23M-$4.09-11.28 Is CBLL or LIVN more profitable? CeriBell has a net margin of 0.00% compared to LivaNova's net margin of -17.41%. LivaNova's return on equity of 13.67% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets CeriBellN/A N/A N/A LivaNova -17.41%13.67%6.68% SummaryLivaNova beats CeriBell on 7 of the 12 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$673.34M$10.51B$5.53B$8.95BDividend YieldN/A2.08%5.38%4.08%P/E RatioN/A16.7427.4020.24Price / Sales10.4529.36418.19125.29Price / CashN/A22.8436.6357.47Price / Book3.543.668.085.67Net Income-$40.46M$235.40M$3.16B$248.47M7 Day Performance0.13%2.15%2.81%3.29%1 Month Performance10.41%3.00%3.69%5.18%1 Year PerformanceN/A-10.21%35.30%21.35% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.1229 of 5 stars$18.93+1.6%$32.14+69.8%N/A$673.34M$65.44M0.00N/ALIVNLivaNova2.5131 of 5 stars$45.02-1.6%$59.29+31.7%-12.6%$2.49B$1.25B-11.012,900News CoveragePositive NewsWRBYWarby Parker2.2137 of 5 stars$21.94+0.2%$22.88+4.3%+37.1%$2.29B$771.32M-182.833,780NVCRNovoCure3.7138 of 5 stars$17.80-1.1%$32.83+84.5%+4.9%$2.01B$605.22M-11.791,488Positive NewsLMATLeMaitre Vascular2.6068 of 5 stars$83.05+0.6%$97.83+17.8%+3.8%$1.87B$219.86M41.94490EYENational Vision2.6642 of 5 stars$23.01-0.7%$18.67-18.9%+92.2%$1.83B$1.82B-69.7313,411ENOVEnovis3.5587 of 5 stars$31.36-1.3%$58.00+84.9%-24.2%$1.82B$2.11B-2.257,367Positive NewsCNMDCONMED4.6769 of 5 stars$52.10-0.1%$62.20+19.4%-19.5%$1.61B$1.31B13.713,900AORTArtivion2.5514 of 5 stars$31.17-0.1%$32.00+2.7%+18.8%$1.33B$388.54M-62.341,600CDRECadre3.6998 of 5 stars$31.94-0.3%$37.50+17.4%-5.3%$1.30B$567.56M33.622,284TNDMTandem Diabetes Care4.3087 of 5 stars$18.64-1.6%$33.43+79.3%-57.1%$1.26B$940.20M-6.712,650Positive News Related Companies and Tools Related Companies LivaNova Alternatives Warby Parker Alternatives NovoCure Alternatives LeMaitre Vascular Alternatives National Vision Alternatives Enovis Alternatives CONMED Alternatives Artivion Alternatives Cadre Alternatives Tandem Diabetes Care Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CBLL Stock Alerts